| For: | Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2016; 22(22): 5183-5192 [PMID: 27298561 DOI: 10.3748/wjg.v22.i22.5183] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i22/5183.htm |
| Number | Citing Articles |
| 1 |
Jie Li, Zhao-Ping Chu, Hua Han, Yuan Zhang, Fei Tian, Jun-Qin Zhang, Xiang-Hua Huang. Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3. Human Cell 2019; 32(2) doi: 10.1007/s13577-018-00225-1
|
| 2 |
Hao Guan, Weiming Li, Yuanyuan Li, Jichang Wang, Yan Li, Yanan Tang, Shaoying Lu, Chih-Hsin Tang. MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2. PLOS ONE 2017; 12(12) doi: 10.1371/journal.pone.0189490
|
| 3 |
Bilegsaikhan Enkhnaran, Guang-Cong Zhang, Ning-Ping Zhang, Hai-Ning Liu, Hao Wu, Shi Xuan, Xiang-Nan Yu, Guang-Qi Song, Xi-Zhong Shen, Ji-Min Zhu, Xiu-Ping Liu, Tao-Tao Liu, Dan Zhao. microRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-xL/p27 Signaling Pathway in Hepatocellular Carcinoma. Journal of Oncology 2022; 2022 doi: 10.1155/2022/1971559
|
| 4 |
Meng-Jie Bai, Na Zhou, Wei Dong, Guang-Xing Li, Wei Cong, Xing-Quan Zhu. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China. International Journal of Infectious Diseases 2018; 71 doi: 10.1016/j.ijid.2018.04.003
|
| 5 |
Min Ding, Juan Yang, XueLi Zeng, Pei Liu, ShunLing Zhang, Sheng Zheng. MicroRNA-642a-5p Targets DNA Damage-Inducible Transcript 4 to Suppress Hepatitis B Virus Hepatoma Carcinoma Cell. Jundishapur Journal of Microbiology 2024; 17(3) doi: 10.5812/jjm-145798
|
| 6 |
Noreen McBrearty, Alla Arzumanyan, Eugene Bichenkov, Salim Merali, Carmen Merali, Mark Feitelson. Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice. Neoplasia 2021; 23(5) doi: 10.1016/j.neo.2021.04.004
|
| 7 |
Caimei Huang, Guohua Hu. Shikonin suppresses proliferation and induces apoptosis in endometrioid endometrial cancer cells via modulating miR-106b/PTEN/AKT/mTOR signaling pathway. Bioscience Reports 2018; 38(2) doi: 10.1042/BSR20171546
|
| 8 |
Xingjun Li, Xianghua Yi, Chuanding Bie, Zhemin Wang. Expression of miR‑106 in endometrial carcinoma RL95‑2 cells and effect on proliferation and invasion of cancer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.8926
|
| 9 |
Jun Lu, Jin-Huan Wei, Zi-Hao Feng, Zhen-Hua Chen, Yong-Qian Wang, Yong Huang, Yong Fang, Yan-Ping Liang, Jun-Jie Cen, Yi-Hui Pan, Bing Liao, Wen-Fang Chen, Wei Chen, Jun-Hang Luo. miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling. Oncotarget 2017; 8(13) doi: 10.18632/oncotarget.15591
|
| 10 |
Yili Tao, Shoubin Zhan, Yanbo Wang, Geyu Zhou, Hongwei Liang, Xi Chen, Hong Shen. Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32734-2
|
| 11 |
Jasmine Samal, Manish Kandpal, Perumal Vivekanandan. HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14652-x
|
| 12 |
Márta Sárközy, Zsuzsanna Kahán, Tamás Csont. A myriad of roles of miR-25 in health and disease. Oncotarget 2018; 9(30) doi: 10.18632/oncotarget.24662
|
| 13 |
Xiangang Cao, Qian Yang, Qing Yu. Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma. Open Forum Infectious Diseases 2020; 7(12) doi: 10.1093/ofid/ofaa498
|
| 14 |
Wei Yan, Dean Rao, Feimu Fan, Huifang Liang, Zunyi Zhang, Hanhua Dong. Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1407434
|
| 15 |
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
|
| 16 |
Nicole Ludwig, Anne Hecksteden, Mustafa Kahraman, Tobias Fehlmann, Thomas Laufer, Fabian Kern, Tim Meyer, Eckart Meese, Andreas Keller, Christina Backes. Spring is in the air: seasonal profiles indicate vernal change of miRNA activity. RNA Biology 2019; 16(8) doi: 10.1080/15476286.2019.1612217
|
| 17 |
Xian Qin, Jing Chen, Long Wu, Zhisu Liu. MiR-30b-5p acts as a tumor suppressor, repressing cell proliferation and cell cycle in human hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017; 89 doi: 10.1016/j.biopha.2017.02.062
|
| 18 |
Shreyas Hulusemane Karunakara, Prasanna Kumar Santhekadur. MicroRNA clusters as regulators in progressive fatty liver disease Spectrum: from mechanistic insights to therapeutic opportunities. Biochemical and Biophysical Research Communications 2026; 819 doi: 10.1016/j.bbrc.2026.153846
|
| 19 |
Nana Li, Yuan Miao, Yujia Shan, Bing Liu, Yang Li, Lifen Zhao, Li Jia. RETRACTED ARTICLE: MiR-106b and miR-93 regulate cell
progression by suppression of PTEN via PI3K/Akt pathway in breast
cancer. Cell Death & Disease 2017; 8(5) doi: 10.1038/cddis.2017.119
|
| 20 |
|
| 21 |
Chang-Long He, Ming Liu, Zhao-Xia Tan, Ya-Jun Hu, Qiao-Yue Zhang, Xue-Mei Kuang, Wei-Long Kong, Qing Mao. Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1. World Journal of Gastroenterology 2018; 24(2): 226-236 doi: 10.3748/wjg.v24.i2.226
|
| 22 |
Weige Tan, Gehao Liang, Xinhua Xie, Wenguo Jiang, Luyuan Tan, Andrew J. Sanders, Zihao Liu, Yun Ling, Wenjing Zhong, Zhenluan Tian, Wanyi Lin, Chang Gong. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer. The Oncologist 2019; 24(11) doi: 10.1634/theoncologist.2018-0697
|
| 23 |
Aferin Beilerli, Valentin Kudriashov, Albert Sufianov, Andrey Kostin, Sema Begliarzade, Tatiana Ilyasova, Yanchao Liang, Albert Mukhamedzyanov, Ozal Beylerli. Regulation and mechanism of action of miRNAs on insulin resistance in skeletal muscles. Non-coding RNA Research 2023; 8(2) doi: 10.1016/j.ncrna.2023.02.005
|
| 24 |
Xiaojing Li, Xianpeng Zeng. Shikonin suppresses progression and epithelial–mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR‐106b/SMAD7/TGF‐β signaling pathway. Cell Biology International 2020; 44(2) doi: 10.1002/cbin.11247
|
| 25 |
Aline de Conti, Juliana Festa Ortega, Volodymyr Tryndyak, Kostiantyn Dreval, Fernando Salvador Moreno, Ivan Rusyn, Frederick A. Beland, Igor P. Pogribny. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis. Oncotarget 2017; 8(51) doi: 10.18632/oncotarget.19774
|
| 26 |
Javid Sadri Nahand, Farah Bokharaei‐Salim, Arash Salmaninejad, Abolfazl Nesaei, Fatemeh Mohajeri, Azadeh Moshtzan, Alireza Tabibzadeh, Mohammad Karimzadeh, Mohsen Moghoofei, Arezo Marjani, Shoeleh Yaghoubi, Hossein Keyvani. microRNAs: Key players in virus‐associated hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(8) doi: 10.1002/jcp.27956
|
| 27 |
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. International Journal of Molecular Sciences 2019; 20(6) doi: 10.3390/ijms20061358
|
| 28 |
Yue Zhang, Chao Wei, Cong-Cong Guo, Rong-Xiu Bi, Jin Xie, Dong-Hui Guan, Chuan-Hua Yang, Yue-Hua Jiang. Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis. Oncotarget 2017; 8(63) doi: 10.18632/oncotarget.20883
|
| 29 |
Surendra Kumar Sagar. miR-106b as an emerging therapeutic target in cancer. Genes & Diseases 2022; 9(4) doi: 10.1016/j.gendis.2021.02.002
|
| 30 |
Xueyan Xu, Jun Wu, Guifang Ren, Qiang Hu. miR‑181c expression in neuroblastoma children and proliferation of neuroblastoma M17 cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10602
|
| 31 |
Ke Xu, Wenhua Xiong, Shoujun Zhao, Bin Wang. MicroRNA‑106b serves as a prognostic biomarker and is associated with cell proliferation, migration, and invasion in osteosarcoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10666
|
| 32 |
Tianpeng Zhang, Allancer Nunes, Ryan O'Kelly, Luise Angelini, Michal M. Masternak, Yousin Suh, Xiao Dong, Laura J. Niedernhofer, Paul D. Robbins. Identification of miR-106b-5p as a senolytic miRNA. eBioMedicine 2025; 117 doi: 10.1016/j.ebiom.2025.105810
|
| 33 |
Jaitip Tipanee, Mario Di Matteo, Warut Tulalamba, Ermira Samara-Kuko, Jiri Keirsse, Jo A. Van Ginderachter, Marinee Khim Chuah, Thierry VandenDriessche. Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons. Molecular Therapy - Nucleic Acids 2020; 19 doi: 10.1016/j.omtn.2020.01.015
|
| 34 |
Yanying Zhao, Qing Ren, Kongxi Zhu. Serum miR-106b upregulation predicts poor prognosis in patients with colorectal cancer. Cancer Biomarkers 2018; doi: 10.3233/CBM-181246
|
| 35 |
Xiao-Peng Zhu, Si-An Pan, Zhou Chu, Yu-Xiang Zhou, Yong-Kai Huang, De-Qing Han. LncRNA GAS5 regulates epithelial-mesenchymal transition and viability of glioma cells by targeting microRNA-106b and regulating PTEN expression. Neuroscience Research 2021; 170 doi: 10.1016/j.neures.2020.08.009
|
| 36 |
Jun Ma, Tingting Yan, Yongrui Bai, Ming Ye, Chunhui Ma, Xiumei Ma, Lei Zhang. TMEM100 negatively regulated by microRNA‑106b facilitates cellular apoptosis by suppressing survivin expression in NSCLC. Oncology Reports 2021; 46(2) doi: 10.3892/or.2021.8136
|
| 37 |
Liansheng Zhang, Yougan Chen, Zhenjie Wang, Qiang Xia. LncRNA PSMG3-AS1 is upregulated in prostate carcinoma and downregulates miR-106b through DNA methylation. Systems Biology in Reproductive Medicine 2023; 69(4) doi: 10.1080/19396368.2023.2187269
|
| 38 |
Tiecheng Zhang, Jia Qi, Changzhu Zhang. The effect of three-dimensional ultrasound and magnetic resonance imaging in the staging diagnosis of endometrial cancer with hepatitis B virus infection and construction of mathematical model. Results in Physics 2021; 25 doi: 10.1016/j.rinp.2021.104307
|
| 39 |
Dai Shimizu, Yoshikuni Inokawa, Fuminori Sonohara, Kenichi Inaoka, Shuji Nomoto. Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors. Oncology Reports 2017; 37(5) doi: 10.3892/or.2017.5541
|
| 40 |
Xinqiang Huang, Jill Magnus, Vivek Kaimal, Priya Karmali, Jian Li, Marlena Walls, Rene Prudente, Eric Sung, Mehran Sorourian, Robin Lee, Scott Davis, Xia Yang, Heather Estrella, Edmund C. Lee, B. Nelson Chau, Adam Pavlicek, Sonya Zabludoff. Lipid Nanoparticle–Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth. Molecular Cancer Therapeutics 2017; 16(5) doi: 10.1158/1535-7163.MCT-16-0613
|
| 41 |
Weiqi Yin, Junfeng Chen, Guoyao Wang, Dongxu Zhang. MicroRNA‑106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10343
|
| 42 |
Ibrahim H. Aboughaleb, Marwa Matboli, Sherif M. Shawky, Yasser H. El-Sharkawy. Integration of transcriptomes analysis with spectral signature of total RNA for generation of affordable remote sensing of Hepatocellular carcinoma in serum clinical specimens. Heliyon 2021; 7(3) doi: 10.1016/j.heliyon.2021.e06388
|
| 43 |
A. L. Guarnieri, C. G. Towers, D. J. Drasin, M. U. J. Oliphant, Z. Andrysik, T. J. Hotz, R. L. Vartuli, E. S. Linklater, A. Pandey, S. Khanal, J. M. Espinosa, H. L. Ford. The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L. Oncogene 2018; 37(28) doi: 10.1038/s41388-018-0239-7
|
| 44 |
Junbi Gao, Liya Liu, Gailing Li, Mingbo Cai, Chaoyue Tan, Xiaoxiao Han, Liping Han. LncRNA GAS5 confers the radio sensitivity of cervical cancer cells via regulating miR-106b/IER3 axis. International Journal of Biological Macromolecules 2019; 126 doi: 10.1016/j.ijbiomac.2018.12.176
|
| 45 |
Fan Zhu, Zhao Lv, Ying-Ying Tang, Lan-Zhuo-Yin Zheng, Wan-Yue Yin, Yu-Xin Wei, Li-Juan Liu, Yu-Feng Yuan, Ming-He Zhang. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(31): 4706-4735 doi: 10.3748/wjg.v29.i31.4706
Abstract(1032) |
Core Tip(1107) |
Full Article(HTML)(4789)
|
Full Article (PDF)-1349K(345)
|
Full Article with Cover (PDF)-6652K(422)
|
Full Article (Word)-973K(49)
|
Full Article (XML)-569K(170)
|
Audio-1688K(17)
|
Peer-Review Report-263K(149)
|
Answering Reviewers-79K(149)
|
Supplementary Material-253K(162)
|
Times Cited (15)
|
Total Visits (7436)
|
Open
|
| 46 |
Soudeh Ghafouri-Fard, Bashdar Mahmud Hussen, Solat Eslami. Identification of miR-125a and miR-106b signature as a potential diagnostic biomarker in breast cancer tissues. Pathology - Research and Practice 2024; 256 doi: 10.1016/j.prp.2024.155277
|
| 47 |
Guoyun Li, Wei Zhang, Li Gong, Xiaoping Huang. MicroRNA 125a-5p Inhibits Cell Proliferation and Induces Apoptosis in Hepatitis B Virus-Related Hepatocellular Carcinoma by Downregulation of ErbB3. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2019; 27(4) doi: 10.3727/096504017X15016337254623
|